Streetbeat News

Stock Prices

AVGO

Deep-pocketed investors have shown unusual options activity in Broadcom (NASDAQ:AVGO), with a significant number of calls and puts indicating a divided sentiment. The options activity suggests a price window of $1100 to $1600 for AVGO. Analysts have a consensus target price of $1550, with Jefferies recently lowering its rating to Buy.

Portfolio Pulse from Benzinga Insights

May 28, 2024 | 1:46 pm

DELL

Financial giants have made a bearish move on Dell Technologies (NYSE:DELL) with 60% of options trades showing bearish tendencies. The stock is currently trading at $167.76, up by 4.73%, but RSI indicators suggest it may be overbought. Analysts have mixed ratings with target prices ranging from $98 to $170. Earnings announcement is expected in 2 days.

Portfolio Pulse from Benzinga Insights

May 28, 2024 | 1:46 pm

FSLR

High-rolling investors have shown a bearish sentiment towards First Solar (NASDAQ:FSLR) through significant options trading activity. Benzinga's options scanner identified 10 trades, with 60% being bearish. The trading activity suggests a price range of $190.0 to $320.0 for FSLR over the next three months. Analysts have mixed ratings, with an average price target of $272.4.

Portfolio Pulse from Benzinga Insights

May 28, 2024 | 1:46 pm

GME

The U.S. financial markets will transition from a T+2 to a T+1 settlement cycle on May 28, 2024. This change aims to reduce counterparty risk and improve liquidity but will require significant operational and technological adjustments. The shift was partly motivated by issues highlighted during the 2021 meme stock frenzy involving GameStop (NYSE:GME).

Portfolio Pulse from Piero Cingari

May 28, 2024 | 1:45 pm

APDN

Applied DNA Sciences (APDN) shares have resumed trading after a temporary halt.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 1:43 pm

CORT

Corcept Therapeutics (NASDAQ:CORT) announced that its GRACE Phase 3 trial for relacorilant in patients with hypercortisolism met its primary endpoint. The trial showed significant improvements in hypertension and hyperglycemia, and the drug was well-tolerated. The company plans to submit a New Drug Application in Q3. CORT shares rose 11.4% following the news.

Portfolio Pulse from Vandana Singh

May 28, 2024 | 1:39 pm

SINT

SiNtx Technologies shares were halted on a circuit breaker due to a significant drop in stock price, now down by 39.8%.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 1:38 pm

APDN

Applied DNA Sciences (APDN) shares were halted on a circuit breaker due to a significant drop, with the stock now down 55.8%.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 1:37 pm

APDN

Applied DNA Sciences (APDN) shares have resumed trading after a temporary halt.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 1:37 pm

APDN

Applied DNA Sciences has announced the pricing of a $12 million public offering, consisting of 9,230,769 units at $1.30 per unit.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 1:33 pm